UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Common genetic variants in the TP53 pathway and their impact on cancer

Journal of molecular cell biology, 2019-07, Vol.11 (7), p.578-585

2019

Volltextzugriff (PDF)

Influence of MDM2 SNP309 and SNP285 status on the risk of cancer in the breast, prostate, lung and colon

International journal of cancer, 2015-07, Vol.137 (1), p.96-103

2015

Volltextzugriff (PDF)

The correlation between MDM2 SNP309 T > G polymorphism and hepatocellular carcinoma risk – A meta-analysis

Human gene (Amsterdam, Netherlands), 2022-12, Vol.34, p.201087, Article 201087

2022

Volltextzugriff (PDF)

TP53 mutations and MDM2SNP309 identify subgroups of AML patients with impaired outcome

European journal of haematology, 2015-04, Vol.94 (4), p.355-362

2015

Volltextzugriff (PDF)

Introduction of the MDM2 T309G Mutation in Primary Human Retinal Epithelial Cells Enhances Experimental Proliferative Vitreoretinopathy

Investigative ophthalmology & visual science, 2017-10, Vol.58 (12), p.5361-5367

2017

Volltextzugriff (PDF)

A case‐control study on the SNP309T → G and 40‐bp Del1518 of the MDM2 gene and a systematic review for MDM2 polymorphisms in the patients with breast cancer

Journal of clinical laboratory analysis, 2020-12, Vol.34 (12), p.e23529-n/a

2020

Volltextzugriff (PDF)

Association between MDM2 SNP309 and endometrial cancer risk: A PRISMA-compliant meta-analysis

Medicine (Baltimore), 2018-12, Vol.97 (49), p.e13273-e13273

2018

Volltextzugriff (PDF)

Genomic approach to identify association of environmental bisphenol-A (BPA) in daily use plastics as molecular disruptors in breast cancer

Human gene (Amsterdam, Netherlands), 2022-05, Vol.32, p.101026, Article 101026

2022

Volltextzugriff (PDF)

MDM2 SNP309 and SNP285 Act as Negative Prognostic Markers for Non-small Cell Lung Cancer Adenocarcinoma Patients

Journal of Cancer, 2017-01, Vol.8 (12), p.2154-2162

2017

Volltextzugriff (PDF)

Association of the MDM2 SNP285 and SNP309 Genetic Variants with the Risk, Age at Onset and Prognosis of Breast Cancer in Central European Women: A Hospital-Based Case-Control Study

International journal of molecular sciences, 2019-01, Vol.20 (3), p.509

2019

Volltextzugriff (PDF)

A cohort study on the association of MDM2 SNP309 with lung cancer risk in Bangladeshi population

The Korean Journal of Internal Medicine, 2020, 35(3), , pp.672-681

2020

Volltextzugriff (PDF)

Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysis

Breast cancer research and treatment, 2010-02, Vol.120 (1), p.211-216

2010

Volltextzugriff (PDF)

Associations between the MDM2 promoter P1 polymorphism del1518 (rs3730485) and incidence of cancer of the breast, lung, colon and prostate

Oncotarget, 2016-05, Vol.7 (19), p.28637-28646

2016

Volltextzugriff (PDF)

The mouse double minute 2 polymorphism is associated with both decreased p53 expression and poor clinicopathological outcomes of gastric cancer

Journal of cancer research and therapeutics, 2021-10, Vol.17 (6), p.1438-1445

2021

Volltextzugriff (PDF)

Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia

Cell cycle (Georgetown, Tex.), 2010-07, Vol.9 (14), p.2836-2840

2010

Volltextzugriff (PDF)

MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer

International journal of cancer, 2012-12, Vol.131 (11), p.2710-2716

2012

Volltextzugriff (PDF)

Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer

Oncology reports, 2013-07, Vol.30 (1), p.25-34

2013

Volltextzugriff (PDF)

TP53 mutations and MDM2(SNP309) identify subgroups of AML patients with impaired outcome

European journal of haematology, 2015-04, Vol.94 (4), p.355-362

2015

Volltextzugriff (PDF)

Interactions between MDM2 and TP53 Genetic Alterations, and Their Impact on Response to MDM2 Inhibitors and Other Chemotherapeutic Drugs in Cancer Cells

Clinical cancer research, 2009-12, Vol.15 (24), p.7602-7607

2009

Volltextzugriff (PDF)

MDM4 SNP34091 (rs4245739) and its effect on breast‐, colon‐, lung‐, and prostate cancer risk

Cancer medicine (Malden, MA), 2015-12, Vol.4 (12), p.1901-1907

2015

Volltextzugriff (PDF)

Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma

Pediatric blood & cancer, 2014-10, Vol.61 (10), p.1867-1870

2014

Volltextzugriff (PDF)

MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis

Journal of experimental & clinical cancer research, 2013-11, Vol.32 (1), p.85-85, Article 85

2013

Volltextzugriff (PDF)

Association of MDM2 SNP309, Age of Onset, and Gender in Cutaneous Melanoma

Clinical cancer research, 2009-04, Vol.15 (7), p.2573-2580

2009

Volltextzugriff (PDF)

MDM2 Gene Amplification Is Correlated to Tumor Progression but not to the Presence of SNP309 or TP53 Mutational Status in Primary Colorectal Cancers

Molecular cancer research, 2008-02, Vol.6 (2), p.205-211

2008

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(74)

Sprache

Englisch
(74)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(69)
Science & Technology
(69)
Humans
(62)
Proto-Oncogene Proteins C-Mdm2 - Genetics
(59)
Polymorphism, Single Nucleotide
(47)
Female
(46)
Oncology
(44)
Snp309
(40)
Middle Aged
(33)
Genotype
(31)
Male
(31)
Mdm2
(31)
Mdm2 Snp309
(29)
Genetic Predisposition To Disease
(28)
Biological And Medical Sciences
(25)
Medical Sciences
(25)
Polymorphism
(25)
Aged
(23)
Case-Control Studies
(22)
Risk Factors
(22)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Common genetic variants in the TP53 pathway and their impact on cancer

Influence of MDM2 SNP309 and SNP285 status on the risk of cancer in the breast, prostate, lung and colon

The correlation between MDM2 SNP309 T > G polymorphism and hepatocellular carcinoma risk – A meta-analysis

TP53 mutations and MDM2SNP309 identify subgroups of AML patients with impaired outcome

Introduction of the MDM2 T309G Mutation in Primary Human Retinal Epithelial Cells Enhances Experimental Proliferative Vitreoretinopathy

A case‐control study on the SNP309T → G and 40‐bp Del1518 of the MDM2 gene and a systematic review for MDM2 polymorphisms in the patients with breast cancer

Association between MDM2 SNP309 and endometrial cancer risk: A PRISMA-compliant meta-analysis

Genomic approach to identify association of environmental bisphenol-A (BPA) in daily use plastics as molecular disruptors in breast cancer

MDM2 SNP309 and SNP285 Act as Negative Prognostic Markers for Non-small Cell Lung Cancer Adenocarcinoma Patients

Association of the MDM2 SNP285 and SNP309 Genetic Variants with the Risk, Age at Onset and Prognosis of Breast Cancer in Central European Women: A Hospital-Based Case-Control Study

A cohort study on the association of MDM2 SNP309 with lung cancer risk in Bangladeshi population

Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysis

Associations between the MDM2 promoter P1 polymorphism del1518 (rs3730485) and incidence of cancer of the breast, lung, colon and prostate

The mouse double minute 2 polymorphism is associated with both decreased p53 expression and poor clinicopathological outcomes of gastric cancer

Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia

MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer

Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649)

Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer

TP53 mutations and MDM2(SNP309) identify subgroups of AML patients with impaired outcome

Interactions between MDM2 and TP53 Genetic Alterations, and Their Impact on Response to MDM2 Inhibitors and Other Chemotherapeutic Drugs in Cancer Cells

MDM4 SNP34091 (rs4245739) and its effect on breast‐, colon‐, lung‐, and prostate cancer risk

Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma

MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis

Association of MDM2 SNP309, Age of Onset, and Gender in Cutaneous Melanoma

MDM2 Gene Amplification Is Correlated to Tumor Progression but not to the Presence of SNP309 or TP53 Mutational Status in Primary Colorectal Cancers

Suchergebnisse filtern